Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1262 to 1311 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 23 (ec 2.7.1.37) (muscle-specific serine kinase 1) (mssk-1). [source:swissprot;acc:q9upe1]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5894.47\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6383.73\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.083\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp binding protein 2. [source:refseq;acc:nm\_019096]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5685.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6156.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08292\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic checkpoint serine/threonine-protein kinase bub1 beta (ec 2.7.1.-) (hbubr1) (mad3/bub1-related protein kinase) (mitotic checkpoint kinase mad3l). [source:swissprot;acc:o60566]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5528.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5985.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08265\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyridoxine 5'-phosphate oxidase. [source:refseq;acc:nm\_018129]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phafin 2; ph and fyve domain-containing protein 2. [source:refseq;acc:nm\_024613]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5885\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6371.14\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08261\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 1 (ec 1.3.99.5) (steroid 5-alpha-reductase 1) (sr type 1) (s5ar). [source:swissprot;acc:p18405]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-oxo-5-alpha-steroid 4-dehydrogenase 2 (ec 1.3.99.5) (steroid 5-alpha-reductase 2) (sr type 2) (5 alpha-sr2). [source:swissprot;acc:p31213]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal membrane protein 2 (22 kda peroxisomal membrane protein). [source:swissprot;acc:q9nr77]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6437.99\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6969.67\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08258\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock-related 70 kda protein 2 (heat shock 70 kda protein 2). [source:swissprot;acc:p54652]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock 70 kda protein 1 (hsp70.1) (hsp70-1/hsp70-2). [source:swissprot;acc:p08107]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock cognate 71 kda protein. [source:swissprot;acc:p11142]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dehydrodolichyl diphosphate synthase. [source:refseq;acc:nm\_024887]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6350.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6874.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08252\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor hmr (early response protein nak1) (tr3 orphan receptor). [source:swissprot;acc:p22736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6744.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear hormone receptor nor-1 (neuron-derived orphan receptor 1) (mitogen induced nuclear orphan receptor). [source:swissprot;acc:q92570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6744.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08249\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1283\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nurr1 (immediate-early response protein not) (transcriptionally inducible nuclear receptor). [source:swissprot;acc:p43354]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6229.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6742.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1284\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xenotropic and polytropic retrovirus receptor. [source:refseq;acc:nm\_004736]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6413.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6941.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08235\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1285\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytosolic nonspecific dipeptidase (glutamate carboxypeptidase-like protein 1). [source:swissprot;acc:q96kp4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6207.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6718.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08234\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1286\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4a11 precursor (ec 1.14.15.3) (cypiva11) (fatty acid omega-hydroxylase) (p-450 hk omega) (lauric acid omega-hydroxylase) (cyp4aii) (p450-hl-omega). [source:swissprot;acc:q02928]\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08218\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f3 (ec 1.14.13.30) (cypivf3) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:q08477]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1288\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1289\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
likely ortholog of rat cytochrome p450 4x1. [source:refseq;acc:nm\_178033]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1291\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f2 (ec 1.14.13.30) (cypivf2) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:p78329]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1292\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f11 (ec 1.14.14.1) (cypivf11). [source:swissprot;acc:q9hbi6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1293\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj18d14.4 (cytochrome p450, subfamily iva, polypeptide 11). [source:sptrembl;acc:q9ntl5]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1294\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 3. [source:swissprot;acc:p58005]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6120.65\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1295\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4b1 (ec 1.14.14.1) (cypivb1) (p450-hp). [source:swissprot;acc:p13584]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1296\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1297\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 2 (hi95). [source:swissprot;acc:p58004]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6120.65\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1298\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 1 (p53-regulated protein pa26). [source:swissprot;acc:q9y6p5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6120.62\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1299\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome oxidase biogenesis protein oxa1, mitochondrial precursor (oxa1-like protein) (oxa1hs). [source:swissprot;acc:q15070]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5589.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6047.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08204\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1300\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l34, mitochondrial precursor (l34mt). [source:swissprot;acc:q9bq48]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial precursor (ec 1.5.5.1) (etf-qo) (etf-ubiquinone oxidoreductase) (etf dehydrogenase) (electron-transferring- flavoprotein dehydrogenase). [source:swissprot;acc:q16134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6618.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7161.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08203\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1302\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 4 (ec 1.11.1.-) (prx-iv) (thioredoxin peroxidase ao372) (thioredoxin-dependent peroxide reductase a0372) (antioxidant enzyme aoe372) (aoe37-2). [source:swissprot;acc:q13162]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6343.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6862.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine-rich motor neuron 1; cysteine-rich repeat-containing protein s52 precursor. [source:refseq;acc:nm\_016441]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6334.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6852.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08185\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8550.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9248.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08154\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1305\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaminyl-trna synthetase (ec 6.1.1.18) (glutamine--trna ligase) (glnrs). [source:swissprot;acc:p47897]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5500.92\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5949.26\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0815\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
spermidine synthase (ec 2.5.1.16) (putrescine aminopropyltransferase) (spdsy). [source:swissprot;acc:p19623]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1307\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycyl-trna synthetase (ec 6.1.1.14) (glycine--trna ligase) (glyrs). [source:swissprot;acc:p41250]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamyl trna synthetase. [source:sptrembl;acc:o14563]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein ad-016 (protein cgi-116) (x0009). [source:swissprot;acc:q9y3c0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6110.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6607.81\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08146\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (tak1-binding protein 1). [source:swissprot;acc:q15750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6051.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6544.17\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exocyst complex component sec8. [source:swissprot;acc:q96a65]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6221.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6727.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08142\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/